Genetically modified botulinum toxin carrying alpaca-derived nanobodies followed active botulinum into nerves and disabled it in two separate animal studies, and the technique could be used to treat botulism. The therapy reversed nerve paralysis in mice given a lethal dose of botulinum toxin, and similar outcomes were obtained in guinea pigs and macaque monkeys.